Pyxs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pyxs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pyxs Today - Breaking & Trending Today

abrdn plc Purchases Shares of 708,303 Pyxis Oncology, Inc. (NASDAQ:PYXS)

Abrdn plc acquired a new position in Pyxis Oncology, Inc. (NASDAQ:PYXS – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund acquired 708,303 shares of the company’s stock, valued at approximately $1,275,000. Several other large investors have also recently modified their […] ....

Leerink Partnrs , Pyxis Oncology Inc , Exchange Commission , Schulhoff Co , Commonwealth Equity Services , Acadian Asset Management , Royal Bank , Pyxis Oncology , Free Report , Equity Services , Asset Management , Decheng Capital Management , Get Free Report , Visit Holdingschannel , Pyxis Oncology Daily , Nasdaq Pyxs , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Pyxis Oncology (NASDAQ:PYXS) Given Outperform Rating at Royal Bank of Canada

Royal Bank of Canada reiterated their outperform rating on shares of Pyxis Oncology (NASDAQ:PYXS – Free Report) in a research note released on Friday morning, Benzinga reports. The firm currently has a $7.00 price objective on the stock. PYXS has been the topic of several other reports. Leerink Partnrs reissued an outperform rating on shares […] ....

Nova Scotia , Leerink Partnrs , Blackrock Inc , Vanguard Group Inc , Royal Bank , Pyxis Oncology Inc , Citadel Advisors , Pyxis Oncology , Free Report , Get Free Report , Pyxis Oncology Daily , Nasdaq Pyxs , Reiterated Rating , Royal Bank Of Canada ,

HC Wainwright Increases Pyxis Oncology (NASDAQ:PYXS) Price Target to $7.00

Pyxis Oncology (NASDAQ:PYXS – Free Report) had its price target upped by HC Wainwright from $4.00 to $7.00 in a research report sent to investors on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. Other equities research analysts have also issued reports about the company. BTIG Research began coverage […] ....

Leerink Partnrs , Blackrock Inc , Vanguard Group Inc , York Mellon Corp , Citigroup Inc , Pyxis Oncology Inc , Pyxis Oncology , Free Report , Oncology Trading Down , New York Mellon Corp , State Street Corp , Street Corp , Get Free Report , Pyxis Oncology Daily , Nasdaq Pyxs , Boost Price Target , Hc Wainwright ,

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Average Recommendation of "Buy" by Analysts

Pyxis Oncology, Inc. (NASDAQ:PYXS – Get Free Report) has earned an average rating of “Buy” from the eight research firms that are presently covering the company, MarketBeat Ratings reports. Eight investment analysts have rated the stock with a buy rating. The average 12 month price target among brokerages that have updated their coverage on the […] ....

William Blair , Leerink Partnrs , Prelude Capital Management , Harvest Investment Services , Pyxis Oncology Inc , Commonwealth Equity Services , Pyxis Oncology , Get Free Report , Marketbeat Ratings , Investment Advisers , Equity Services , Capital Management , Investment Services , Exoduspoint Capital Management , Point Capital Management , Get Free , Pyxis Oncology Daily , Nasdaq Pyxs ,